On August 14, 2026, City Hill, LLC filed a Schedule 13G/A regarding its holdings in Erasca, Inc. (ERAS). The filing indicates that City Hill, LLC is the record holder of 12,899,360 shares of Common Stock, representing approximately 3.7% of the company. However, the filing is a joint statement including Jonathan E. Lim ...

MMCAP International Inc. SPC and MM Asset Management Inc. filed a Schedule 13G/A on August 14, 2026, disclosing a significant new ownership stake in CleanCore Solutions, Inc. (ZONE). The filing indicates that the reporting persons collectively hold 13,950,444 shares of common stock, representing 6.3% of the company bas...

On August 14, 2026, Clearline Capital LP, alongside Clearline Capital LLC and Marc Majzner, filed a Schedule 13G/A with the SEC disclosing a new 5.1% ownership stake in Xperi Inc. (XPER). The reporting persons collectively hold 2,475,135 shares of Common Stock as of the event date of June 30, 2026. This filing represen...

On August 14, 2026, Vivo Opportunity Fund Holdings, L.P., along with its affiliates Vivo Opportunity, LLC, Vivo Opportunity Cayman Fund, L.P., and Vivo Opportunity Cayman, LLC, filed a Schedule 13G/A regarding their holdings in Clene Inc. (CLNN). The filing discloses a beneficial ownership of 1,321,675 shares of common...

MPM BioImpact LLC has filed an amendment (Amendment No. 1) to its Schedule 13G regarding its holdings in Climb Bio, Inc. (Ticker: CLYM). As of the event date of June 30, 2026, and the filing date of August 14, 2026, MPM BioImpact LLC reported a beneficial ownership of 0 shares of Common Stock, representing 0.0% of the ...

RiverNorth Capital Management, LLC filed a Schedule 13G/A on August 14, 2026, regarding its holdings in Clough Global Equity Fund (GLQ). The filing, which serves as Amendment No. 3, indicates that as of the event date on June 30, 2026, RiverNorth Capital Management beneficially owns 523,377 shares of common stock. This...

RiverNorth Capital Management, LLC filed a Schedule 13G/A on August 14, 2026, disclosing a reduced position in Clough Global Opportunities Fund (GLO). As of the event date on June 30, 2026, the filer reported beneficial ownership of 1,081,372 shares of beneficial interest, representing a 2.53% stake in the company. Thi...

On August 14, 2026, Fourthstone LLC and associated entities filed a Schedule 13G/A regarding their holdings in CoastalSouth Bancshares, Inc. (COSO). The filing indicates that Fourthstone LLC, acting as a registered investment adviser, beneficially owns 225,211 shares of common stock, representing a 1.87% ownership stak...

Van Eck Associates Corporation filed a Schedule 13G/A on August 14, 2026, disclosing a significant ownership stake in Coeur Mining, Inc. (CDE). As of the event date on June 30, 2026, the investment adviser reported beneficial ownership of 67,029,794 shares of common stock, representing a 6.5% ownership interest in the ...

Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. filed a Schedule 13G/A on August 14, 2026, disclosing a 7.21% ownership stake in Cohen Circle Acquisition Corp II (CCII). The filing reports beneficial ownership of 1,875,436 Class A shares. This amendment (Amendment No. 2) reflects an internal reorganiz...

Fort Baker Capital Management LP, along with Steven Patrick Pigott and Fort Baker Capital, LLC, has filed a Schedule 13G/A for Cohen Circle Acquisition Corp. II (CCII). The filing, dated August 14, 2026, reveals that the reporting persons collectively hold 2,546,827 Class A ordinary shares, representing a 9.8% ownershi...

On August 14, 2026, Meteora Capital, LLC filed a Schedule 13G/A with the SEC, reporting a new significant stake in Cohen Circle Acquisition Corp. II (CCII). As of the event date on June 30, 2026, the firm beneficially owns 1,541,000 shares of Class A common stock, representing a 5.92% ownership stake in the company. Th...

CoinFund Management LLC has filed an amendment to its Schedule 13G regarding Eightco Holdings Inc. (ticker: ORBS), reporting that it has fully exited its position in the company. As of the event date of June 30, 2026, the filer reported owning zero shares of common stock, representing a 0.0% ownership stake. This compl...

Meteora Capital, LLC, along with its Managing Member Vik Mittal, filed a Schedule 13G/A on August 14, 2026, disclosing a new position in Columbus Acquisition Corp (COLA). As of the event date on June 30, 2026, the reporting persons beneficially own 141,742 shares of Class A common stock, representing a 3.15% ownership ...

Meteora Capital, LLC and its Managing Member, Vik Mittal, filed a Schedule 13G/A on August 14, 2026, disclosing a new ownership position in Columbus Acquisition Corp (COLA). As of the event date on June 30, 2026, the reporting persons beneficially own 141,742 shares of Class A common stock, representing a 3.15% stake i...

On August 14, 2026, Commodore Capital LP and its affiliates filed a Schedule 13G/A disclosing a 9.9% ownership stake in Vistagen Therapeutics, Inc. (VTGN). The reporting group, which includes Commodore Capital Master LP and managing partners Robert Egen Atkinson and Michael Kramarz, reported beneficial ownership of 4,2...

Commodore Capital LP, along with Commodore Capital Master LP and managing partners Michael Kramarz and Robert Egen Atkinson, filed a Schedule 13G/A on August 14, 2026, disclosing a 1.8% stake in Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc., ticker: MNMD). The filing indicates that as of June 30, 2...

On August 14, 2026, Commodore Capital LP and its affiliates filed a Schedule 13G/A reporting a significant new ownership position in SAB Biotherapeutics, Inc. (SABS). As of the event date of June 30, 2026, the filers reported aggregate beneficial ownership of 8,948,170 shares of Common Stock, representing 9.9% of the c...

On August 14, 2026, Commodore Capital LP and its affiliates filed a Schedule 13G/A disclosing a significant new position in Relay Therapeutics, Inc. (RLAY). As of the event date of June 30, 2026, the filers reported aggregate beneficial ownership of 12,000,000 shares of Common Stock, representing a 5.5% stake in the co...

Commodore Capital LP, along with Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz, filed a Schedule 13G/A on August 14, 2026, regarding their holdings in Karyopharm Therapeutics Inc. (KPTI). The filing indicates that the reporting persons have fully exited their position in the company's common st...

Commodore Capital LP, along with its Master Fund and managing partners Michael Kramarz and Robert Egen Atkinson, filed a Schedule 13G/A on August 14, 2026, disclosing a 9.9% stake in Immunic, Inc. (IMUX). This represents an increase from a previously reported 0.0% position, involving the beneficial ownership of 1,511,8...

Commodore Capital LP, along with Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz, filed an amendment to their Schedule 13G regarding their holdings in Palisade Bio, Inc. (PALI). As of the event date of June 30, 2026, the reporting persons have reported a 0.0% ownership stake, effectively exiting ...

On August 14, 2026, Fourthstone LLC and its affiliates filed a Schedule 13G/A regarding their holdings in Community West Bancshares (CWBC). The filing indicates that Fourthstone LLC, acting as a registered investment adviser, now beneficially owns 100 shares of the Issuer's common stock. This position represents a 0.00...

On August 14, 2026, Brannin J. McBee, Meghan Q. Bennett, and several associated entities (collectively, the 'Reporting Persons') filed Amendment No. 2 to their Schedule 13G regarding CoreWeave, Inc. This filing serves as the final amendment and constitutes an exit filing for the Reporting Persons. As of June 30, 2026, ...

Cormorant Asset Management, LP, and its managing member, Bihua Chen, have filed a Schedule 13G/A regarding their holdings in EyePoint, Inc. (EYPT). As of the event date of June 30, 2026, the reporting persons beneficially own 7,000,000 shares of common stock, representing an 8.35% ownership stake in the company. This f...